Ticker League

Edwards Lifesciences (EW) Profit Bridge

See what drove Edwards Lifesciences's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

TTM

Revenue YoY

+13.81%

Operating Income YoY

+22.25%

Net Income YoY

-73.80%

Net Margin Δ

-5813 bps

Net income bridge for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: -$3.09B-73.80%

Profit bridge breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income$4.18B
  • Revenue$765M
  • Cost of Revenue-$233M
  • Operating Expenses-$215M
  • Other Income / Expense-$634M
  • Income Tax-$48.6M
  • Other Items-$2.72B
  • Net Income$1.09B
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation